摘要
目的探讨改良式经尿道前列腺等离子切除术治疗前列腺增生症的临床疗效。方法选取2016年3月至2020年5月本院收治的68例前列腺增生症患者作为研究对象,采用数字奇偶法分为两组,每组34例。改良组采用改良式经尿道前列腺等离子切除术治疗,常规组采用经尿道前列腺等离子切除术治疗,比较两组术中失血量、最大尿流率(Qmax)评分、国际前列腺症状评分表(IPSS)评分及生命质量(QOL)评分。结果改良组术中失血量(75.65±3.15)ml,少于常规组的(128.39±4.07)ml,差异有统计学意义(P<0.05);治疗前,两组Qmax评分、IPSS评分及QOL评分比较差异无统计学意义;治疗后,改良组Qmax评分(19.35±2.16)分高于常规组的(15.92±2.09)分,IPSS评分(8.26±1.55)分及QOL评分(2.19±0.43)分均低于常规组(9.97±1.71)分及QOL评分(4.07±0.58)分,差异有统计学意义(P<0.05)。结论改良式经尿道前列腺等离子切除术治疗前列腺增生症效果显著,可明显减少患者术中失血量,提升Qmax评分,降低IPSS评分及QOL评分,改善预后,值得临床推广应用。
Objective To investigate the clinical effect of modified transurethral plasma resection of prostate in the treatment of prostatic hyperplasia.Methods A total of 68 patients with prostatic hyperplasia admitted to our hospital from March 2016 to May 2020 were selected as the research subjects,and they were divided into two groups by digital parity method,with 34 cases in each group.The modified group was treated with modified transurethral plasma resection of prostate,while the conventional group was treated with transurethral plasma resection of prostate.The intraoperative blood loss,the maximum flow rate(Qmax)score,International prostate symptom score scale(IPSS)score and quality of life(QOL)score were compared between the two groups.Results The intraoperative blood loss in the modified group was(75.65±3.15)ml,which was less than(128.39±4.07)ml in the conventional group,and the difference was statistically significant(P<0.05).Before treatment,there was no significant difference in Qmax score,IPSS score and QOL score between the two groups.After treatment,the Qmax score of modified group([19.35±2.16]scores)was higher than that of conventional group([15.92±2.09]scores),IPSS score([8.26±1.55]scores)and QOL score([2.19±0.43]scores)were lower than those of conventional group([9.97±1.71]scores)and([4.07±0.58]scores),the difference was statistically significant(P<0.05).Conclusion Modified transurethral plasma resection of prostate is effective in the treatment of prostatic hyperplasia,which can significantly reduce the intraoperative blood loss,increase the Qmax score,reduce the IPSS score and QOL score,and improve the prognosis,it is worthy of clinical application.
作者
万明忠
韩松
夏剑迪
WAN Mingzhong;HAN Song;XIA Jiandi(Department of Urology,Haicheng Central Hospital,Anshan,Liaoning,114200,China)
出处
《当代医学》
2022年第29期53-55,共3页
Contemporary Medicine
